Table: Stella Pharma -2021/22 parent results

Stella Pharma

10/05/2022 07:20

May 10 (Reuters)- 
          Stella Pharma Corporation 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to        NEXT   
              Mar 31, 2022    Mar 31, 2021    Mar 31, 2023      YEAR     
                 LATEST         YEAR-AGO         COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST     H1 FORECAST 
  Sales          100 mln         205 mln         192 mln                 
               (-51.4 pct)                     (+91.8 pct)               
  Operating   loss 741 mln    loss 680 mln    loss 948 mln               
  Recurring   loss 764 mln    loss 656 mln    loss 933 mln               
  Net         loss 767 mln    loss 659 mln    loss 936 mln               
  EPS        loss 27.34 yen  loss 32.90 yen  loss 32.64 yen              
  Ann Div          NIL             NIL             NIL                   
  -Q2 Div          NIL             NIL             NIL                   
  -Q4 Div          NIL             NIL             NIL                   
  
  NOTE - Stella Pharma Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T